Cargando…
MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers
Gastrointestinal cancer accounts for the 20 most frequent cancer diseases worldwide and there is a constant urge to bring new therapeutics with new mechanism of action into the clinical practice. Quantity of in vitro and in vivo evidences indicate, that exogenous change in pathologically imbalanced...
Autores principales: | Merhautova, Jana, Demlova, Regina, Slaby, Ondrej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037200/ https://www.ncbi.nlm.nih.gov/pubmed/27729862 http://dx.doi.org/10.3389/fphar.2016.00329 |
Ejemplares similares
-
miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015) -
MicroRNA as an Early Biomarker of Neonatal Sepsis
por: Jouza, Martin, et al.
Publicado: (2022) -
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2017) -
MicroRNA-206: a Promising Theranostic Marker
por: Novák, Jan, et al.
Publicado: (2014) -
Research progress on microRNA in gout
por: Xie, Jing, et al.
Publicado: (2022)